Literature DB >> 24182768

Production of interferon α and β, pro-inflammatory cytokines and the expression of suppressor of cytokine signaling (SOCS) in obese subjects infected with influenza A/H1N1.

Elí Terán-Cabanillas1, Maricela Montalvo-Corral1, Erika Silva-Campa1, Graciela Caire-Juvera1, Silvia Y Moya-Camarena1, Jesús Hernández2.   

Abstract

BACKGROUND & AIMS: Obesity was recognized as an independent risk factor for morbidity and mortality during last influenza A/H1N1 pandemic. Mechanisms involved in the high mortality risk from obesity during influenza A virus include reduced type I interferon production and delayed pro-inflammatory response, which lead to a higher rate of morbidity and mortality in murine models. In this study, we evaluated the production of type I interferons, pro-inflammatory and anti-inflammatory cytokines in peripheral blood mononuclear cells (PBMCs) from obese and lean subjects with and without confirmed infection of influenza A/H1N1. The expression levels of the suppressor of cytokine signaling-1 (SOCS1), SOCS3 and nuclear factor-kB were also evaluated.
METHODS: Cytokines were measured by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) and/or by ELISA in PBMCs stimulated with toll like receptor-3 (TLR-3) and TLR-7 ligands. The mRNA expression of SOCS1 and SOCS3 were evaluated by qRT-PCR.
RESULTS: The obese volunteers infected with influenza A/H1N1 showed a diminished ability to produce type I interferon in response to TLR-3 ligand. Interestingly, the pro-inflammatory response was also affected in TLR-3 stimulated PBMCs. Obese influenza-free volunteers showed an increased basal expression of SOCS3, but not SOCS1. During influenza infection, SOCS1 and SOCS3 expression was higher in the lean infected volunteers in contrast to those who were obese infected.
CONCLUSIONS: These data suggest that obesity is related to TLR-3 impairment and explain, at least in part, the inadequate immune response of obese individuals during infection with influenza A/H1N1 virus.
Copyright © 2013 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  IFN; Influenza; Obesity; SOCS3; TLR

Mesh:

Substances:

Year:  2013        PMID: 24182768     DOI: 10.1016/j.clnu.2013.10.011

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  9 in total

1.  Influenza in obese travellers: increased risk and complications, decreased vaccine effectiveness.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  J Travel Med       Date:  2019-05-10       Impact factor: 8.490

2.  Role of Leptin and SOCS3 in Inhibiting the Type I Interferon Response During Obesity.

Authors:  Elí Terán-Cabanillas; Jesús Hernández
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

3.  Downregulation of microRNA‑221 facilitates H1N1 influenza A virus replication through suppression of type‑IFN response by targeting the SOCS1/NF‑κB pathway.

Authors:  Nali Zhang; Yuan Ma; Yuheng Tian; Yafei Zhou; Yuhua Tang; Shaobo Hu
Journal:  Mol Med Rep       Date:  2021-05-06       Impact factor: 2.952

4.  Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.

Authors:  J M Vera-Zertuche; J Mancilla-Galindo; M Tlalpa-Prisco; P Aguilar-Alonso; M M Aguirre-García; O Segura-Badilla; M Lazcano-Hernández; H I Rocha-González; A R Navarro-Cruz; A Kammar-García; J de J Vidal-Mayo
Journal:  Epidemiol Infect       Date:  2021-04-29       Impact factor: 2.451

Review 5.  Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

6.  Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR‑146a.

Authors:  Rui Li; Lianxin Wang
Journal:  Mol Med Rep       Date:  2019-10-15       Impact factor: 2.952

Review 7.  The role of dysregulated immune responses in COVID-19 pathogenesis.

Authors:  S Tahaghoghi-Hajghorbani; P Zafari; E Masoumi; M Rajabinejad; R Jafari-Shakib; B Hasani; A Rafiei
Journal:  Virus Res       Date:  2020-10-16       Impact factor: 3.303

8.  Baicalin Induces a Potent Innate Immune Response to Inhibit Respiratory Syncytial Virus Replication via Regulating Viral Non-Structural 1 and Matrix RNA.

Authors:  Sheng Qin; Xianzhang Huang; Shaogang Qu
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

9.  Influenza a virus antagonizes type I and type II interferon responses via SOCS1-dependent ubiquitination and degradation of JAK1.

Authors:  Yinping Du; Fan Yang; Qiuxia Wang; Nuo Xu; Yizhang Xie; Sujuan Chen; Tao Qin; Daxin Peng
Journal:  Virol J       Date:  2020-06-12       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.